16 results
6-K
EX-99.1
GLPG
Galapagos NV
2 Nov 23
Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma
7:15am
this will benefit both companies and ensure that Jyseleca® will continue to be available to patients who can benefit from it. Galapagos has a skilled workforce
6-K
EX-99.1
GLPG
Galapagos NV
31 Mar 23
Current report (foreign)
6:05am
highly skilled team, is the perfect fit for NovAliX in order to complement our DNA-Encoded-Libraries database2 and cryo-EM3 driven discovery engine
6-K
EX-99.3
GLPG
Galapagos NV
11 May 21
Current report (foreign)
2:10pm
could not have been prevented by the exercise of skill, diligence, and prudence that would be reasonably and ordinarily expected from a skilled
6-K
EX-99.2
eny36ik4 mrbqucejh9
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
04b1p 4nabwkhj1arud
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
20-F
124ft8tni e4tgdkg
25 Mar 16
Annual report (foreign)
12:00am
DRS/A
EX-10
o51l3jp92b9ks w9tmc
4 Mar 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10
aegppchebyo ii
4 Mar 15
Draft registration statement (amended)
12:00am
DRS
6r8nkbvdq7zgzhp
6 Feb 15
Draft registration statement
12:00am
- Prev
- 1
- Next